News Daily News Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR Todd Neale July 27, 2015
News Daily News Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR Todd Neale July 27, 2015
News Daily News ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves Yael L. Maxwell July 15, 2015
News Daily News ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR Yael L. Maxwell July 15, 2015
News Daily News La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia Todd Neale July 13, 2015
News Daily News FDA Approves Heart Failure Drug That Comes With Survival Benefit Todd Neale July 13, 2015
News Daily News Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years July 07, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015
News Daily News El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años July 07, 2015
News Daily News Una Peor Movilidad es Fuertemente Predictiva de la Mortalidad en Pacientes TAVR Yael L. Maxwell July 06, 2015
News Daily News Poor Mobility Strongly Predicts Mortality in TAVR Patients Yael L. Maxwell July 06, 2015